Elanco Animal Health (NYSE:ELAN – Get Free Report) and Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.
Valuation & Earnings
This table compares Elanco Animal Health and Aveanna Healthcare”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Elanco Animal Health | $4.44 billion | 2.63 | $338.00 million | $0.06 | 391.13 |
| Aveanna Healthcare | $2.02 billion | 0.89 | -$10.93 million | $0.36 | 23.86 |
Institutional and Insider Ownership
97.5% of Elanco Animal Health shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 0.9% of Elanco Animal Health shares are owned by company insiders. Comparatively, 7.8% of Aveanna Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Elanco Animal Health and Aveanna Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Elanco Animal Health | 0.78% | 7.41% | 3.64% |
| Aveanna Healthcare | 3.29% | -143.55% | 4.71% |
Volatility and Risk
Elanco Animal Health has a beta of 1.87, meaning that its share price is 87% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 2.06, meaning that its share price is 106% more volatile than the S&P 500.
Analyst Ratings
This is a summary of current recommendations for Elanco Animal Health and Aveanna Healthcare, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Elanco Animal Health | 1 | 3 | 7 | 2 | 2.77 |
| Aveanna Healthcare | 0 | 6 | 5 | 0 | 2.45 |
Elanco Animal Health presently has a consensus target price of $23.78, suggesting a potential upside of 1.32%. Aveanna Healthcare has a consensus target price of $10.69, suggesting a potential upside of 24.42%. Given Aveanna Healthcare’s higher possible upside, analysts clearly believe Aveanna Healthcare is more favorable than Elanco Animal Health.
Summary
Elanco Animal Health beats Aveanna Healthcare on 9 of the 15 factors compared between the two stocks.
About Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
